| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89986-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06442-100ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99876-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06475-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1072 | |||
| Carrier Free | AF1072-SP | |||
![Flow Cytometry: Siglec-5/CD170 Antibody (110) [NBP2-89986] - Analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-110-Flow-Cytometry-NBP2-89986-img0001.jpg "Flow Cytometry: Siglec-5/CD170 Antibody (110) [NBP2-89986] - Analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")
![Flow Cytometry: Siglec-5/CD170 Antibody (07) [NBP3-06442] - Flow cytometric analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-07-Flow-Cytometry-NBP3-06442-img0001.jpg "Flow Cytometry: Siglec-5/CD170 Antibody (07) [NBP3-06442] - Flow cytometric analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")
